Functional Bloating. Flatulence and related conditions
Conditions
Interventions
Intervention 1: Intervention group: Functional bloating patients are taught the teachings of the style of life based on Iranian medicine. These fifteen trainings have already been prepared and standa
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with functional bloating symptoms consistent with ROME III criteria include: 1.Recurrent feeling of bloating or visible distension at least 3 days/month in the last 3 months; 2.Insufficient criteria for a diagnosis of functional dyspepsia, irritable bowel syndrome, or other functional GI disorder. Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis
Exclusion criteria
Exclusion criteria: Existing gastrointestinal ulcer diagnosis by internal medicine specialist; Acute abdominal pain; Gastrointestinal organ diseases such as inflammatory bowel disease, peptic ulcer or duodenal ulcer and functional constipation are recognized by an internal medicine specialist; Severe mental illness; Severe uncontrolled systemic diseases such as cardiac, pulmonary, and hepatic impairment; Taking aspirin or nonsteroidal anti-inflammatory drugs, corticosteroids, antibiotics, proton pump inhibitor drugs; Pregnancy or breastfeeding; Severe weight loss, black stool or bitumen color;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of the functional bloating complications questionaire. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Functional bloating complications questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of epigastric distension after the usual meal. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.;The amount of distension and bulging in the lower abdomen. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.;The intensity of rectal gas (flatulence). Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.;The amount of burping (eructation). Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.;The intensity of abdominal rumbling. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.;The intensity of early satiety in eating (The inability to finish the usual meal). Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.;The severity of postprandial fullness after a typical meal. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue scale.;The intensity of bloating after bloatable food eating. Timepoint: To evaluate the severity of the complication at the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Visual analogue s | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Reza Sharifi Alun-abadi
Bagheiat-allah University of Medical Sciences
Outcome results
None listed